Loops in the natural history of cervical cancer

The Lancet Oncology

Volumn 12, Issue 11, 2011, Pages 986-

  Petry, Karl Ulrich ^a  

^a Klinikum Wolfsburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CARCINOGENESIS; CORRELATIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MALIGNANT TRANSFORMATION; NOTE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK REDUCTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 80053386126     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70255-8     Document Type: Letter

References (3)

1. Castellsagué X, Díaz M, Vaccarella S, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol 2011, published online Sept 13. 10.1016/S1470-2045(11)70223-6.
2. Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994, 57:836-840.
3. Arbyn M, Castellsague X, de SS, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, published online April 6. 10.1093/annonc/mdr015.